Bernzott Capital Advisors Catalent, Inc. Transaction History

Bernzott Capital Advisors

$217 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$45.44 - $74.26 $339,027 - $554,053	-7,461 Reduced 8.42%	81,099 $5.33 Million
Q4 2022 Jan 18, 2023	BUY	$41.39 - $81.0 $482,400 - $944,055	11,655 Added 15.16%	88,560 $0
Q3 2022 Dec 22, 2022	SELL	$72.36 - $113.1 $578 - $904	-8 Reduced 0.01%	76,905 $5.57 Million
Q3 2022 Oct 18, 2022	SELL	$72.36 - $113.1 $36,758 - $57,454	-508 Reduced 0.66%	76,913 $5.57 Million
Q2 2022 Jul 25, 2022	SELL	$87.2 - $114.05 $348,276 - $455,515	-3,994 Reduced 4.91%	77,421 $8.31 Million
Q1 2022 Apr 20, 2022	BUY	$94.19 - $124.49 $1.87 Million - $2.47 Million	19,852 Added 32.25%	81,415 $9.03 Million
Q4 2021 Feb 03, 2022	SELL	$119.57 - $139.07 $419,092 - $487,440	-3,505 Reduced 5.39%	61,563 $7.88 Million
Q3 2021 Oct 19, 2021	SELL	$109.17 - $142.35 $420,850 - $548,759	-3,855 Reduced 5.59%	65,068 $8.66 Million
Q2 2021 Aug 10, 2021	SELL	$100.34 - $115.69 $64,016 - $73,810	-638 Reduced 0.92%	68,923 $7.45 Million
Q1 2021 May 13, 2021	SELL	$101.51 - $125.27 $729,349 - $900,064	-7,185 Reduced 9.36%	69,561 $7.33 Million
Q4 2020 Feb 12, 2021	SELL	$85.88 - $105.36 $1.65 Million - $2.02 Million	-19,178 Reduced 19.99%	76,746 $7.99 Million
Q3 2020 Nov 12, 2020	SELL	$72.74 - $92.5 $16.7 Million - $21.2 Million	-229,585 Reduced 70.53%	95,924 $8.22 Million
Q2 2020 Aug 19, 2020	SELL	$48.02 - $79.04 $14.3 Million - $23.5 Million	-296,887 Reduced 47.7%	325,509 $23.9 Million
Q1 2020 May 14, 2020	SELL	$36.95 - $62.95 $5.07 Million - $8.63 Million	-137,170 Reduced 18.06%	622,396 $32.3 Million
Q4 2019 Feb 12, 2020	BUY	$47.06 - $56.64 $1.04 Million - $1.25 Million	22,108 Added 3.0%	759,566 $42.8 Million
Q3 2019 Nov 12, 2019	SELL	$47.45 - $58.05 $3.15 Million - $3.86 Million	-66,450 Reduced 8.27%	737,458 $35.1 Million
Q2 2019 Aug 12, 2019	BUY	$39.26 - $54.21 $195,828 - $270,399	4,988 Added 0.62%	803,908 $43.6 Million
Q1 2019 May 16, 2019	BUY	$29.84 - $43.92 $40,433 - $59,511	1,355 Added 0.17%	798,920 $32.4 Million
Q4 2018 Feb 11, 2019	BUY	$29.95 - $46.34 $236,605 - $366,086	7,900 Added 1.0%	797,565 $24.9 Million
Q3 2018 Nov 14, 2018	SELL	$40.12 - $45.55 $583,144 - $662,069	-14,535 Reduced 1.81%	789,665 $36 Million
Q2 2018 Aug 10, 2018	SELL	$38.72 - $42.52 $169,012 - $185,599	-4,365 Reduced 0.54%	804,200 $33.7 Million
Q1 2018 May 10, 2018	SELL	$39.4 - $47.39 $383,165 - $460,867	-9,725 Reduced 1.19%	808,565 $33.2 Million
Q4 2017 Feb 13, 2018	BUY	$37.27 - $43.02 $474,260 - $547,429	12,725 Added 1.58%	818,290 $33.6 Million
Q3 2017 Nov 13, 2017	BUY	$33.75 - $41.67 $27.2 Million - $33.6 Million	805,565	805,565 $32.2 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

Vanguard Group Inc Valley Forge, PA

20.2M
Shares

$1.28 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

15.4M
Shares

$975 Million
0.02% of portfolio
State Street Corp Boston, MA

7.45M
Shares

$473 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

6.4M
Shares

$406 Million
0.06% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.52M
Shares

$287 Million
0.14% of portfolio

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bernzott Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Bernzott Capital Advisors with notifications on news.

Account